靶向辐射耐受持留细胞作为抑制胶质母细胞瘤放射抵抗和复发的策略
该临床前研究建立了一种适用于放射生物学研究的新型模型,鉴定出辐射耐受持留(RTP)亚群;RTP通过优先激活DNA损伤修复和促进干性驱动放射抵抗,机制涉及NF-κB-YY1-miR-103a调控轴抑制FGF2-XRCC3轴,转铁蛋白功能化纳米颗粒(Tf-NPs)可改善放射敏感性并带来显著生存获益。
要点
- RTP细胞通过优先激活DNA损伤修复和促进干性驱动放射抵抗。
- 持续辐射激活NF-κB信号 cascade,促进p65核转位,增强YY1表达,直接抑制miR-103a转录。
- 恢复miR-103a表达可抑制FGF2-XRCC3轴并降低放射抵抗能力。
核心结论
- 作者认为NF-κB-YY1-miR-103a调控轴对RTP细胞驱动放射抵抗和复发不可或缺,结果鉴定了一种改善复发/难治性GBM患者生存的新策略。
研究设计与样本
- 临床前研究,建立新型模型并进行筛选鉴定辐射耐受持留(RTP)亚群,对RTP和亲本细胞行RNA测序获取mRNA和miRNA表达谱。
主要发现
- RTP细胞通过优先激活DNA损伤修复和促进干性驱动放射抵抗。
- 持续辐射激活NF-κB信号 cascade并促进p65核转位,增强YY1表达,YY1直接抑制miR-103a转录。
- 恢复miR-103a表达抑制FGF2-XRCC3轴并降低放射抵抗能力。
- Tf-NPs改善放射敏感性并提供显著生存获益。
临床怎么用
- 作者建议NF-κB-YY1-miR-103a调控轴是RTP细胞驱动放射抵抗和复发不可或缺的,结果鉴定了一种改善复发/难治性GBM患者生存的新策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Compelling evidence suggests that glioblastoma (GBM) recurrence results from the expansion of a subset of tumor cells with robust intrinsic or therapy-induced radioresistance. However, the mechanisms underlying GBM radioresistance and recurrence remain elusive. To overcome obstacles in radioresistance research, we present a novel preclinical model ideally suited for radiobiological studies. METHODS: With this model, we performed a screen and identified a radiation-tolerant persister (RTP) subpopulation. RNA sequencing was performed on RTP and parental cells to obtain mRNA and miRNA expression profiles. The regulatory mechanisms among NF-κB, YY1, miR-103a, XRCC3, and FGF2 were investigated by transcription factor activation profiling array analysis, chromatin immunoprecipitation, western blot analysis, luciferase reporter assays, and the MirTrap system. Transferrin-functionalized nanoparticles (Tf-NPs) were employed to improve blood-brain barrier permeability and RTP targeting. RESULTS: RTP cells drive radioresistance by preferentially activating DNA damage repair and promoting stemness. Mechanistic investigations showed that continual radiation activates the NF-κB signaling cascade and promotes nuclear translocation of p65, leading to enhanced expression of YY1, the transcription factor that directly suppresses miR-103a transcription. Restoring miR-103a expression under these conditions suppressed the FGF2-XRCC3 axis and decreased the radioresistance capability. Moreover, Tf-NPs improved radiosensitivity and provided a significant survival benefit. CONCLUSIONS: We suggest that the NF-κB-YY1-miR-103a regulatory axis is indispensable for the function of RTP cells in driving radioresistance and recurrence. Thus, our results identified a novel strategy for improving survival in patients with recurrent/refractory GBM.
引用
- Gu J, Mu N, Jia B, et al. Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma. Neuro Oncol. 2022. PMID: 34905060. doi:10.1093/neuonc/noab288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。